2-(4-Benzylphenoxy)-N,N-diethylethylamine hydrochloride
2-(4-Benzylphenoxy)-N,N-diethylethylamine hydrochloride structure
|
Common Name | 2-(4-Benzylphenoxy)-N,N-diethylethylamine hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 92981-78-7 | Molecular Weight | 603.97300 | |
| Density | N/A | Boiling Point | 397ºC at 760 mmHg | |
| Molecular Formula | C6H12N2NaO12P4Sm---- | Melting Point | N/A | |
| MSDS | USA | Flash Point | 116.8ºC | |
| Name | Radioactive samarium and ethylenediaminetetramethylenephosphonic acid (EDTMP) |
|---|---|
| Synonym | More Synonyms |
| Boiling Point | 397ºC at 760 mmHg |
|---|---|
| Molecular Formula | C6H12N2NaO12P4Sm---- |
| Molecular Weight | 603.97300 |
| Flash Point | 116.8ºC |
| Exact Mass | 603.84600 |
| PSA | 280.51000 |
| LogP | 1.76460 |
| RIDADR | UN 3077 9 / PGIII |
|---|
|
~87%
2-(4-Benzylphen... CAS#:92981-78-7 |
| Literature: Poirot, Marc; De Medina, Philippe; Delarue, Frederic; Perie, Jean-Jacques; Klaebe, Alain; Faye, Jean-Charles Bioorganic and Medicinal Chemistry, 2000 , vol. 8, # 8 p. 2007 - 2016 |
|
~72%
2-(4-Benzylphen... CAS#:92981-78-7 |
| Literature: Kovalainen; Morimoto; Williams; Vepsalainen; Reijonen; Gynther Journal of Labelled Compounds and Radiopharmaceuticals, 1995 , vol. 36, # 12 p. 1147 - 1156 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
|
Enhancement of antitumour activity of cisplatin by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine. HCl in human ovarian cancer cells with intrinsic or acquired resistance to cisplatin.
Eur. J. Cancer 33(1) , 122-8, (1997) This study was designed to the elucidate sensitising effects of the intracellular histamine antagonist, N,N-diethyl-2[4-(phenylmethyl)phenoxy] ethanamine HCl (DPPE) on the antitumour activity of cis-d... |
|
|
Effect of alpha-FMH and DPPE on colony-forming properties of human peripheral progenitor cells.
Curr. Med. Chem. 9(14) , 1349-57, (2002) Endogenous histamine regulates the haematopoiesis. Histidine decarboxylase inhibitor decreases the histamine level, and its intracellular antagonist decreases the histamine effect. The effect of histi... |
|
|
Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
J. Pharm. Pharmacol. 62(8) , 1084-8, (2010) It has been reported that docetaxel is a P-glycoprotein substrate and is metabolized via the cytochrome P450 (CYP) 3A subfamily in rats. Tesmilifene is a substrate of the CYP3A subfamily and is an inh... |
| Diaethyl-[2-(4-benzyl-phenoxy)-aethyl]-amin,Hydrochlorid |
| N,N-diethyl-2-[(4-phenylmethyl)phenoxy]ethanamine hydrochloride |
| Tesmilifene hydrochloride |
| N,N-diethyl-2-<4-(phenylmethyl)phenoxy>-ethaneamine * HCl |
| [2-(4-Benzoylbenzoyloxy)ethyl](dimethyl)[2-(myristoyloxy)-ethyl]ammoniumbromid |
| 2-(4-benzoylbenzoyl)oxyethyl-dimethyl-(2-tetradecanoyloxyethyl)azanium bromide |
| Ethanaminium,2-((4-benzoylbenzoyl)oxy)-N,N-dimethyl-N-(2-((1-oxotetradecyl)oxy)ethyl)-,bromide |
| diethyl-[2-(4-benzyl-phenoxy)-ethyl]-amine,hydrochloride |
| [2-(4-benzylphenoxy)ethyl]diethylammonium chloride |